Grants for Public and State controlled institutions of higher education - Food and Nutrition

This program provides funding to Wisconsin farmers and their partners to conduct research on improving nitrogen use in agriculture through collaborative field studies.

This funding opportunity supports researchers in developing innovative tools that can speed up drug development and improve regulatory processes, ultimately enhancing public health by facilitating faster access to effective treatments.

This funding program provides financial support to non-profit organizations, schools, and municipalities in New York for establishing or expanding urban farms and community gardens to promote local food production and enhance food security.

The Rhode Island Strategic Prevention Framework (SPF) Partnerships for Success (PFS) program is specifically tailored to address gaps in alcohol and marijuana use prevention among youth and young adults aged 12-18 in certain communities. These communities include Newport, Tiverton, Burrillville, and Exeter-West Greenwich, identified as high-need areas for prevention efforts. The program, administered by the Rhode Island Department of Behavioral Healthcare, Developmental Disabilities & Hospitals (BHDDH), collaborates with local community prevention providers to implement evidence-based programming aimed at reducing underage and problematic use of alcohol and marijuana among middle and high school students. Eligible applicants for funding include: Local government entities Academic institutions Non-profit organizations Other relevant agencies Schools/school districts Applicants are required to implement one or more preapproved evidence-based practices from a provided list. The aim is to ensure that interventions are grounded in proven strategies for effectiveness. Key details of the funding opportunity: Funds Available: $200,000.00 Award Amount: $50,000.00 (minimum and maximum) Number of Awards: 4 Average Award Size: $50,000.00 Matching Required: No Through this targeted initiative, the Rhode Island SPF PFS program seeks to empower local stakeholders and organizations to address substance abuse prevention needs in their communities effectively. By providing funding, training, and technical assistance, BHDDH aims to support the implementation of evidence-based prevention strategies tailored to the unique challenges and needs of each identified community.

This funding opportunity provides financial support to organizations in Western North Carolina that enhance community services for older adults and their caregivers, focusing on health, housing, food security, transportation, mental wellness, and social connectivity.

This funding opportunity provides financial support to government entities, non-profit organizations, and universities in Michigan for projects aimed at preventing, detecting, managing, and eradicating invasive species in both terrestrial and aquatic environments.

This Notice of Funding Opportunity (NOFO) requests applications to explore human pancreatic tissues and the immune compartment for the discovery of specific signaling or processing pathways that may contribute to the asymptomatic phase of T1D, the discovery of early biomarkers of T1D pathogenesis, the development of diagnostic tools for the detection and staging of early T1D in at-risk or recently-diagnosed individuals, and/or the identification and biological validation of therapeutic targets for the development of preventative or early treatment strategies. Successful applicants will join the Consortium on Beta Cell Death and Survival (CBDS), whose mission is to better define and detect the mechanisms of beta cell stress and destruction central to the development of T1D in humans, with the long-term goal of protecting the residual beta cell mass in T1D patients as early as possible in the disease process, and of preventing the progression to autoimmunity. The CBDS is part of a collaborative research framework, the Human Islet Research Network (HIRN, https://hirnetwork.org/), whose overall mission is to support innovative and collaborative translational research to understand how human beta cells are lost in T1D, and to find innovative strategies to protect and replace functional beta cell mass in humans. This NOFO will only support studies with a primary focus on increasing our understanding of human disease biology (as opposed to rodent or other animal models). This NOFO will not accept applications proposing a clinical trial.

Notice of Funding Opportunity Description Background The Food and Drug Administration (FDA) protects the public health by ensuring that medical products intended to be marketed in the United States are safe and effective for their intended use. FDA stakeholders are exploring innovative ways to produce scientific evidence in support of regulatory submissions, including the development of new data sources, study designs, methodologies, and technologies. FDA encourages and facilitates the use of such innovative approaches while ensuring that the scientific evidence supporting marketing approvals meet our high evidentiary standards. The Prescription Drug User Fee Act VII (PDUFA VII) commitment letter represents the product of discussions between the FDA, regulated industry, and public stakeholders, as mandated by Congress. The performance and procedural goals and other commitments specified in the PDUFA VII commitment letter apply to aspects of the human drug review program that are important for facilitating timely access to safe, effective, and innovative new medicines for patients. The commitment letter includes goals relating to the use of digital health technologies (DHTs) to support drug development and review. A DHT is a system that uses computing platforms, connectivity, software, and/or sensors, for health care and related uses. DHTs for remote data acquisition in clinical investigations can include hardware and/or software to perform one or more functions. DHTs may rely on or work with other technologies that support their operation, such as general-purpose computing platforms (e.g., smartphones) and communication networks. Among other activities relating to the use of DHTs, FDA has established a Framework for the Use of DHTs in Drug and Biological Product Development to guide the use of DHT-derived data in regulatory decision-making for drugs (hereinafter Framework ). The Framework highlights FDA’s DHT efforts including workshops and demonstration projects; engagement with stakeholders; establishment of internal processes to support the evaluation of DHTs for use in drug development; promotion of shared learning and consistency regarding DHT-based policy, procedure, and analytic tool development; and publication of guidance documents. In addition, FDA’s webpage DHTs for Drug Development (available at: https://www.fda.gov/science-research/science-and-research-special-topics/digital-health-technologies-dhts-drug-development) provides an overview of the ongoing DHT efforts, including demonstration projects. A variety of project types are welcomed under this NOFO, applicable to drugs and biologics (not devices). FDA is particularly interested in projects that evaluate the use of DHTs in drug development. Project Objectives The overarching goal of this notice of funding opportunity (NOFO) is to explore the role of DHTs (e.g., actigraphy, photography, environmental sensors) in the evaluation of new drugs. These projects may involve engagement with researchers from academia, the biopharmaceutical industry, patient groups, and other stakeholders. The objectives of these projects are to advance DHTs for clinical drug development, expand the ability to capture early manifestations of chronic diseases, determine outcomes in populations with unmet medical needs and enhance convenience for trial participants by allowing for remote data acquisition in clinical investigations. The scope includes, but is not limited to, projects that focus on: Comparing digital measurements to traditional measurements in clinical trials to evaluate drugs Developing and evaluating novel endpoints using DHTs to address unmet needs for drug clinical trials (e.g., use of environmental sensors to capture apnea in pediatric patients) Comparing metrics to evaluate continuous measurements (e.g., maximum activity and stamina) Capturing early manifestations of chronic diseases (e.g., dementia) through the use of DHTs

This program provides funding to Illinois-based nonprofits, educational institutions, and government entities to enhance the specialty crop industry, focusing on food safety, research, and support for underserved farmers.

This funding opportunity supports innovative research that investigates how aging affects individuals living with HIV, focusing on improving their health outcomes and addressing related challenges.

This grant provides financial support for early-career clinician-scientists to conduct patient-oriented research in pain management, focusing on developing effective strategies to address chronic pain and the opioid crisis.

This funding opportunity supports U.S. educational institutions in developing programs that train a diverse workforce in research related to diabetes, digestive diseases, and kidney health, through skills courses and research experiences.

This funding opportunity supports innovative, interdisciplinary research projects that aim to fill critical knowledge gaps and advance scientific understanding in areas related to kidney, diabetes, and digestive diseases.

This funding opportunity supports students enrolled in dual-degree medical and research training programs, helping them develop into independent physician-scientists through mentored research and clinical training.

This funding opportunity supports clinical trials aimed at developing new therapies for rare neurodegenerative diseases, such as ALS, and is open to a wide range of eligible organizations, including universities and nonprofits.

The Animal Services Responsive Grant, offered by the San Antonio Area Foundation, aims to improve the quality of life for all animals, educate the community on responsible pet care, and enhance spay/neuter and adoption services. This aligns with the foundation's broader mission to support vital community needs, ensuring that organizations dedicated to animal welfare receive the necessary funding to operate and expand their reach. By focusing on these key areas, the grant seeks to create a more humane environment for animals and foster responsible pet ownership within the community. The primary beneficiaries of this grant are animals in need, as well as the communities and individuals who benefit from enhanced animal welfare services. The grant targets organizations working in specific Texas counties: Atascosa, Bandera, Bexar, Comal, Guadalupe, Kendall, Medina, and Wilson. The impact goals are centered on reducing animal suffering, increasing pet adoptions, promoting spay/neuter initiatives to control pet overpopulation, and educating the public on best practices for animal care. The grant prioritizes nonprofit organizations that demonstrate a clear commitment to these objectives and have a proven track record of serving their local animal populations. The program's priorities include supporting direct animal care services, public education campaigns, and programs that facilitate adoption and spay/neuter. The expected outcomes are a measurable reduction in the number of homeless and neglected animals, an increase in responsible pet ownership, and a more informed community regarding animal welfare issues. Measurable results are tied to the organizational budget and corresponding award amounts, indicating that larger, more established organizations with greater capacity are expected to achieve more significant outcomes. For instance, organizations with budgets over $1,000,000 are eligible for a $50,000 award, implying an expectation of broader impact. The San Antonio Area Foundation's strategic priorities, as demonstrated by this grant, include fostering community well-being through targeted support for critical services. Their theory of change appears to be that by providing financial resources to qualified animal welfare organizations, these organizations will be empowered to implement effective programs that directly address the root causes of animal neglect and overpopulation, ultimately leading to a healthier and more compassionate community for both humans and animals. The eligibility criteria, such as requiring 501(c)(3) status and local operation, ensure that funding is directed to legitimate and impactful entities. This grant does not support endowments, capital campaigns, religious purposes, scholarships, political activities, or lobbying efforts. This restriction further refines the foundation's strategic focus, ensuring that funds are directly applied to programmatic efforts that align with the core goals of animal services. The focus is strictly on responsive grants that address immediate and ongoing needs, rather than long-term institutional building or advocacy.

This funding opportunity supports research initiatives focused on non-communicable diseases related to HIV at institutions in low- and middle-income countries, encouraging innovative projects and collaborations to improve health outcomes for people living with HIV.

This fellowship provides college and graduate students, who have participated in the World Food Prize Youth Program, the opportunity to work with USDA scientists on research and policy initiatives related to agriculture, food, and rural development during a paid summer program.

This Notice of Funding Opportunity (NOFO) seeks to foster new multi-disciplinary teams to address how HIV Comorbidities and co-infections within the missions of NIDDK and NIAID interact with viral reservoirs, potentially confounding cure strategies aimed at either sustained viral suppression or elimination from the body. These teams will mechanistically interrogate the impact of inflammation, metabolic perturbations, or other pathophysiological processes associated with these comorbidities or co-infections on reservoir dynamics, and/or the interplay of these conditions and co-infections on HIV reservoir biology in ways that are likely to interact with potential cure strategies.

This grant provides funding for early stage investigators to pursue innovative and high-risk research projects involving human participants, without the need for preliminary data.